BeStock  
Stocks › Biotechnology › ALNY

Alnylam Pharmaceuticals ALNY

US equityMarket cap rank #427Biotechnology
$236.54 −$10.20 (-4.13%)
Market open · Oct 1, 1:20 pm ET · After hours $246.74 0.00%
Open$248.21
Prev close$246.74
Day range$233.53 – $251.71
Volume868.2K
Market cap$31.65B
P/E (TTM)41.2
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings43.0x
CheapRich

Near the top of its 5-year range · 84th percentile, 5-year average 18.2x

#2431 of 2977 stocks by PE (1 = cheapest)

Price / book24.4x
CheapRich

Around its usual level · 45th percentile, 5-year average -502.5x

#5141 of 5307 stocks by PB (1 = cheapest)

Price / sales6.9x
CheapRich

Near the bottom of its 5-year range · 2nd percentile, 5-year average 18.3x

#4158 of 5144 stocks by PS (1 = cheapest)

Morningstar fair value estimate

Fair value$299.00
Price vs. fair value-20.9%Trading below the estimate
Star rating★★★★☆
Economic moatNarrow
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 24.38 – -502.48 45% (cheaper than usual) #5141 of 5307 (1 = cheapest)
PE 42.99 29.25 18.21 84% (pricier than usual) #2431 of 2977 (1 = cheapest)
PS 6.87 5.18 18.28 2% (cheaper than usual) #4158 of 5144 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★★
Fair value estimate$299.00
Economic moatNarrow
UncertaintyHigh

Discussion

No comments yet — be the first to weigh in on ALNY.

Leave a comment

Scroll to Top